Skip to content

Clinical trials

Completed Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Status: Completed Country / region: Japan Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20061
20101
20111
20121
20141
20151
20171
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Pfizer2
Charite University, Berlin, Germany1
Genzyme, a Sanofi Company1
Institut de Recherches Internationales Servier1
Japan Adult Leukemia Study Group1
Keio University1
Otsuka Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive4
Leukemia, Myeloid, Acute2
Burkitt Lymphoma1
Hematologic Neoplasms1
Lymphoma, Non-Hodgkin1
Multiple Myeloma1
Myelodysplastic Syndromes1
Neoplasms, Plasma Cell1
Philadelphia Chromosome1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.